logo

TVGN

Tevogen Bio Holdings·NASDAQ
--
--(--)
--
--(--)
3.71 / 10
Netural

TVGN's fundamental score is 3.7/10, reflecting sub-par profitability (Profit-MV 0.47) and cash position (Cash-MV -0.07), while asset quality is particularly weak (Asset-MV -0.51). Revenue and net income metrics are also below peers, and the gross margin of 36.7% is average. Historical back-tests show modest one-month returns (4-8%) for most factors, but the low Asset-MV and Revenue-MV rankings limit upside potential. The board's evaluation of a special cash dividend is a positive catalyst, yet it is not sufficient to offset structural weaknesses, resulting in a neutral fundamental stance.

Fundamental(3.71)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-0.26
Score1/3
Weight10.63%
1M Return5.63%
Inventory turnover ratio
Value47.88
Score3/3
Weight9.74%
1M Return5.89%
Gross profit margin (%)
Value36.70
Score1/3
Weight0.31%
1M Return0.22%
Profit-MV
Value0.47
Score2/3
Weight14.88%
1M Return7.95%
Net income-Revenue
Value-0.15
Score2/3
Weight15.08%
1M Return8.04%
PB-ROE
Value31.11
Score3/3
Weight22.38%
1M Return11.66%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.64%
1M Return1.75%
Fixed assets turnover ratio
Value7993.84
Score3/3
Weight2.25%
1M Return1.53%
Asset-MV
Value-0.51
Score0/3
Weight7.35%
1M Return4.17%
Cash-MV
Value-0.07
Score2/3
Weight14.74%
1M Return7.78%
Is TVGN undervalued or overvalued?
  • TVGN scores 3.71/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 0.00% net margin, -1.76 P/E ratio, -7.07 P/B ratio, and -20.00% earnings growth, these metrics solidify its Netural investment rating.